Published in CMAJ on April 02, 2012
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis (2008) 2.88
Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation (2005) 2.69
Early predictors of in-hospital death in infective endocarditis. Circulation (2004) 2.26
Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J (2007) 1.82
Infective endocarditis. Nat Rev Cardiol (2011) 1.77
Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study. Ann Intern Med (1992) 1.67
Management of infective endocarditis. Heart (2006) 1.60
Surgical management of endocarditis: the society of thoracic surgeons clinical practice guideline. Ann Thorac Surg (2011) 1.36
Timing the valve replacement in infective endocarditis involving the brain. J Neurol (2004) 1.23
The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J (2009) 1.14
Impact of stroke on therapeutic decision making in infective endocarditis. J Neurol (2009) 1.10
Impact of early surgery on embolic events in patients with infective endocarditis. Circulation (2010) 0.98
What is the optimal timing for surgery in infective endocarditis with cerebrovascular complications? Interact Cardiovasc Thorac Surg (2011) 0.98
Indications and optimal timing for surgery in infective endocarditis. Heart (2004) 0.89
Treatment strategies for infective endocarditis. Expert Opin Pharmacother (2010) 0.86
Endocarditis and associated complications. Crit Care Med (2007) 0.85
Heart failure associated with infective endocarditis. A review of 40 cases. Br Heart J (1986) 0.84
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med (2004) 11.44
Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med (2006) 10.58
Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. JAMA (2009) 3.08
A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure. Arch Intern Med (2004) 2.68
Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA (2010) 2.61
Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation (2003) 2.61
Association of hospital spending intensity with mortality and readmission rates in Ontario hospitals. JAMA (2012) 2.47
Survival after implantable cardioverter-defibrillator implantation in the elderly. Circulation (2013) 2.30
Bundle branch block patterns and long-term outcomes in heart failure. Int J Cardiol (2010) 2.07
Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol (2004) 2.03
Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation (2011) 2.00
Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart J (2008) 1.92
Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Heart Fail (2012) 1.92
Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med (2012) 1.80
Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols, part 1: background for a statistical method. AAPS PharmSciTech (2007) 1.78
Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization. Am Heart J (2010) 1.76
Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols: part 2--evaluation of a method for determining equivalence. AAPS PharmSciTech (2007) 1.69
Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study. Can J Cardiol (2011) 1.66
Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol (2011) 1.58
Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community. Eur Heart J (2012) 1.53
Using methods from the data-mining and machine-learning literature for disease classification and prediction: a case study examining classification of heart failure subtypes. J Clin Epidemiol (2013) 1.50
How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts. Eur Heart J (2005) 1.45
Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail (2012) 1.35
CCORT/CCS quality indicators for acute myocardial infarction care. Can J Cardiol (2003) 1.35
Diastolic heart failure: mechanisms and controversies. Nat Clin Pract Cardiovasc Med (2008) 1.32
Regression trees for predicting mortality in patients with cardiovascular disease: what improvement is achieved by using ensemble-based methods? Biom J (2012) 1.28
Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007. CMAJ (2012) 1.27
Evaluation of Electronic Medical Record Administrative data Linked Database (EMRALD). Am J Manag Care (2014) 1.22
Validation of physician billing and hospitalization data to identify patients with ischemic heart disease using data from the Electronic Medical Record Administrative data Linked Database (EMRALD). Can J Cardiol (2010) 1.13
Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada. Arch Intern Med (2005) 1.05
Reversible regional wall motion abnormalities on exercise technetium-99m-gated cardiac single photon emission computed tomography predict high-grade angiographic stenoses. J Am Coll Cardiol (2002) 1.03
Constitutively active calcineurin induces cardiac endoplasmic reticulum stress and protects against apoptosis that is mediated by alpha-crystallin-B. Proc Natl Acad Sci U S A (2010) 1.03
Logistic regression had superior performance compared with regression trees for predicting in-hospital mortality in patients hospitalized with heart failure. J Clin Epidemiol (2010) 1.00
Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada. Value Health (2010) 0.95
Comparison of processes of care and clinical outcomes for patients newly hospitalized for heart failure attended by different physician specialists. Am Heart J (2012) 0.93
Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%. Am J Cardiol (2008) 0.90
Association of physical activity and heart failure with preserved vs. reduced ejection fraction in the elderly: the Framingham Heart Study. Eur J Heart Fail (2013) 0.90
Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces. Can J Cardiol (2005) 0.90
Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest. CMAJ (2007) 0.90
Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine. Can J Cardiol (2007) 0.90
Temporal trends in the utilization of echocardiography in Ontario, 2001 to 2009. JACC Cardiovasc Imaging (2013) 0.88
Inequitable distribution of implantable cardioverter defibrillators in Ontario. Int J Technol Assess Health Care (2007) 0.87
The average lifespan of patients discharged from hospital with heart failure. J Gen Intern Med (2012) 0.86
A population-based study to evaluate the effectiveness of multidisciplinary heart failure clinics and identify important service components. Circ Heart Fail (2012) 0.86
Socioeconomic status, functional recovery, and long-term mortality among patients surviving acute myocardial infarction. PLoS One (2013) 0.86
Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure. Circ Heart Fail (2013) 0.86
A metaanalysis comparing surgical thrombectomy, mechanical thrombectomy, and pharmacomechanical thrombolysis for thrombosed dialysis grafts. J Vasc Surg (2002) 0.85
Percutaneous coronary intervention with vs without on-site cardiac surgery backup: a systematic review and meta-analysis. Can J Cardiol (2011) 0.85
Boosted classification trees result in minor to modest improvement in the accuracy in classifying cardiovascular outcomes compared to conventional classification trees. Am J Cardiovasc Dis (2011) 0.85
Outcomes and care of patients with acute heart failure syndromes and cardiac troponin elevation. Circ Heart Fail (2013) 0.84
Association between physician follow-up and outcomes of care after chest pain assessment in high-risk patients. Circulation (2013) 0.84
Occipital condyle fracture with associated hypoglossal nerve injury. Can J Neurol Sci (2006) 0.83
Prediction of emergent heart failure death by semi-quantitative triage risk stratification. PLoS One (2011) 0.82
Achieving quality indicator benchmarks and potential impact on coronary heart disease mortality. Can J Cardiol (2011) 0.81
Postoperative Hypoxemia Is Common and Persistent: A Prospective Blinded Observational Study. Anesth Analg (2015) 0.81
Improving prognosis estimation in patients with heart failure and the cardiorenal syndrome. Int J Nephrol (2011) 0.81
Statin therapy and clinical outcomes in heart failure: a propensity-matched analysis. J Card Fail (2008) 0.80
The contribution of familial and heritable risks in heart failure. Curr Opin Cardiol (2007) 0.80
Evaluating sex differences in population-based utilization of implantable cardioverter-defibrillators: role of cardiac conditions and noncardiac comorbidities. Heart Rhythm (2009) 0.79
A comparison of Chinese and non-Chinese Canadian patients hospitalized with heart failure. BMC Cardiovasc Disord (2013) 0.78
Aortic root remodeling and risk of heart failure in the Framingham Heart study. JACC Heart Fail (2013) 0.78
Are multiple biomarker testing strategies ready for prime time in heart failure? Circ Heart Fail (2009) 0.78
Potential gaps in congestive heart failure management in a rural hospital. Can J Rural Med (2005) 0.78
The challenge of heart failure discharge from the emergency department. Curr Heart Fail Rep (2012) 0.77
The concept of the marginally matched subject in propensity-score matched analyses. Pharmacoepidemiol Drug Saf (2009) 0.76
Differential effects of bundle branch block morphology in heart failure. Int J Cardiol (2010) 0.75
Response to letter regarding article, "Survival after implantable cardioverter-defibrillator implantation in the elderly". Circulation (2014) 0.75
Current use of domperidone and co-prescribing of medications that increase its arrhythmogenic potential among older adults: a population-based cohort study in Ontario, Canada. Drugs Aging (2014) 0.75
Electrocardiographic prediction of the severity of posterior wall perfusion defects on rest technetium-99m Sestamibi myocardial perfusion imaging. J Electrocardiol (2005) 0.75
Do case-generic measures of queue performance for bypass surgery accurately reflect the waiting-list experiences of those most urgent? J Eval Clin Pract (2006) 0.75
Anticoagulation in patients with heart failure. Cardiovasc Hematol Agents Med Chem (2009) 0.75
Reply: "Who Will Be Rehospitalized Next? Targeting Heart Failure Patients With Brittle Dimensions". JACC Heart Fail (2017) 0.75
National trends in cardiovascular care and outcomes. Healthc Q (2010) 0.75
Reply: Readmissions and Diuretic Dosing. JACC Heart Fail (2017) 0.75
Integrated cardiovascular rehabilitation: how do noncardiac and polyvascular disease patients fare? J Cardiopulm Rehabil Prev (2015) 0.75